- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/14 - Heterocyclic compounds containing purine ring systems with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with two methyl radicals in positions 1 and 3 and two methyl radicals in positions 7, 8, or 9
Patent holdings for IPC class C07D 473/14
Total number of patents in this class: 9
10-year publication summary
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
1
|
0
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Fertis India Pvt. Ltd. | 71 |
3 |
| Bristol-myers Squibb Company | 4742 |
2 |
| Endacea, Inc. | 5 |
1 |
| NovaCardia, Inc. | 3 |
1 |
| Ono Pharmaceutical Co., Ltd. | 421 |
1 |
| Beyond Foam Inc. | 2 |
1 |
| Other owners | 0 |